Myomo (MYO) Short term Debt (2019 - 2025)

Myomo's (MYO) quarterly Short term Debt came in at $2.7 million in Q4 2025, up 173.32% on a QoQ basis from $1.0 million in Q3 2025.

Myomo (MYO) Short term Debt (2019 - 2025) Analysis & Trends

Myomo (MYO) has 3 years of Short term Debt data on file, last reported at $2.7 million in Q4 2025.

Quarterly Short term Debt changed N/A year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (changed N/A YoY) and the FY2025 annual result came in at $2.7 million, changed N/A from the prior year.
Short term Debt grew to $2.7 million in Q4 2025, from $1.0 million in the prior quarter.
In the past five years, Short term Debt ranged from a high of $2.7 million in Q4 2025 to a low of $1.0 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	Myomo	67.26 Mn	48.29 Mn	-

Download Data